Location: Home
  • search
  • go
  • Relate News
  • 12/14/2010Zhejiang Jolly Pharma to IPO at Chinext
  • 12/13/2010Xinhua interview vice health minister over public hospital reform pilo...
  • 12/13/2010GE appoints new leader at GE Healthcare China
  • 12/13/2010WSJ: Selling Health Food to China
  • 12/13/2010Former Merck emerging market head to lead Merck KGaA
  • 12/13/2010Shanghai initiates NEDS with 388 additional drugs and zero margins
  • 12/13/2010Central government funded 50,000 new medical institutions in the past ...
  • 12/13/2010Shanghai Fosun acquires leading tuberculosis player Hongqi Pharma
  • 12/10/2010China's public health priority shifts to chronic disease
  • 12/10/2010Chi-Med increases stake in joint venture with Baiyunshan
  • 12/9/2010BioTime signs distribution agreement for greater China markets
  • 12/9/2010Pfizer loses two leading emerging market executives
  • 12/9/2010Pharma industry face increasing government price control globally
  • 12/9/2010Chongqing Lummy Pharma to acquire 100% of Sichuan Hezheng Pharma
  • 12/9/2010DKSH to market Bayer's ED drug Levitra in China
  • 12/9/2010PwC: Healthcare spending of OECD and BRIC countries to rise 51% in the...
  • 12/8/2010Invida to market Sinclair's dermatology and wound care brands in Asia
  • 12/7/2010Beike Biotech ends joint venture with SiriCell
  • 12/7/2010GSK agrees to take over Nanjing Meirui for US$70M
  • 12/6/2010China Pharma Holdings to launch generic version of Crestor in China
  • 12/6/2010Survey by AstraZeneca: China and India to lead in innovation in the ne...
  • 12/6/2010China issues new policy to support social investment in medical sector
  • 12/6/2010SFDA relocates to a new office location
  • 12/6/2010Pfizer CEO Jeff Kindler steps down
  • 12/3/2010Tasly Pharma to raise more funds through private placement
  • 12/3/2010EU raids a number of pharma companies for potential antitrust violatio...
  • 12/3/2010Yaoyou Pharma gets Canadian GMP certification for drug formulations
  • 12/3/2010Merck moves into insulin with SmartCells acquisition
  • 12/2/2010Foreign Companies Fight to Enter Essential Drugs List
  • 12/2/2010GSK: UK's new bribery law to undermine its operations in China
  • Page:539/719 Total number of articles:21568: [First][<<] [537] [538] [539] [540] [541] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group